Myostatin is the protein that puts a ceiling on muscle growth. It is your body’s built-in limiter, preventing muscles from growing beyond what it considers necessary for survival. Reducing myostatin expression — even modestly — can shift your muscle-building potential upward.
What Myostatin Does
Myostatin (also called GDF-8) is a myokine — a signaling protein produced by muscle cells. Its job is to inhibit muscle cell growth and differentiation. Animals with myostatin gene mutations (like Belgian Blue cattle and certain whippet breeds) develop dramatically more muscle mass than their normal counterparts.
In humans, myostatin levels vary between individuals and are influenced by genetics, age, and physical activity. Higher myostatin = more resistance to muscle growth. Lower myostatin = the brakes come off, and muscle hypertrophy proceeds more easily.
Natural Myostatin Inhibitors
Natural myostatin inhibitors are actually quite common. The question is whether any of them reduce myostatin enough to produce noticeable improvements in muscle growth. Here are the most studied options:
Resistance training itself is the most potent natural myostatin reducer. Consistent heavy training downregulates myostatin expression over time. This is partly why trained individuals build muscle more efficiently than beginners — their myostatin levels are already lower from years of training adaptation.
Epicatechin, found in dark chocolate and green tea, has shown myostatin-reducing properties in preliminary studies. The doses used in research (around 150-200mg daily of pure epicatechin) are far higher than what you would get from food, so supplementation is required to test this effect.
Creatine may indirectly reduce myostatin through its effects on muscle cell hydration and gene expression, though this mechanism is still being studied. Given that creatine has dozens of other proven benefits, it should be in virtually everyone’s stack regardless of its myostatin effects.
Follistatin is the body’s natural myostatin blocker — it binds to myostatin and prevents it from signaling. Follistatin-rich foods like fertilized eggs and dark leafy greens may provide modest support, though supplemental follistatin (as a peptide) is the more direct route. This falls firmly into peptide territory and should be evaluated with the same rigor as any other compound. For a deep dive on the direct peptide approach, see my guide on Follistatin 344.
The Biochemistry of Inhibition
Understanding how to reduce myostatin requires a grasp of the signaling pathway. Myostatin binds to the activin type IIB receptor (ActRIIB) on muscle cells, triggering a cascade that suppresses protein synthesis and muscle cell differentiation. This is a textbook application of the Tony Huge Laws of Biochemistry Physics — you have a ligand (myostatin), a receptor, and a downstream effect. To build more muscle, you must interfere with this signal. Natural inhibitors like epicatechin or exercise-induced follistatin work by either downregulating myostatin production or binding to it before it can reach the receptor. The efficiency of this interference dictates the magnitude of the muscle-building response.
Realistic Expectations
No natural supplement is going to give you the physique of a myostatin-knockout animal. The reductions in myostatin from supplements are modest — probably in the 10-20% range at best. But combined with optimized training, nutrition, and other Natty Plus compounds, even a modest reduction in myostatin can contribute meaningfully to long-term muscle accrual. Every percentage point helps when you are doing everything else right. For a comprehensive approach to performance, explore my Ultimate Enhancement Protocols.
Interesting Perspectives
The conversation around myostatin extends far beyond basic supplementation. Here are some unconventional angles and emerging research frontiers:
- The Genetic Frontier: While natural methods offer modest reductions, the future of myostatin inhibition lies in genetic intervention. The concept of gene editing for bodybuilding is no longer science fiction. CRISPR-based techniques to knock out or silence the myostatin gene (MSTN) are in active preclinical development, promising a future where the body’s primary growth limiter can be permanently disabled.
- Cross-Domain Applications: Research into myostatin inhibition isn’t solely for bodybuilders. It’s a major focus in combating sarcopenia (age-related muscle wasting) and cachexia (muscle wasting from chronic diseases like cancer). The therapeutic doses and delivery methods being explored in clinical trials for these conditions often far exceed what’s available in a supplement bottle, highlighting the gap between natural support and pharmaceutical intervention.
- The Stack Synergy Mindset: Isolating myostatin reduction is a limited strategy. The real power comes from stacking it with complementary pathways. For example, reducing myostatin (removing a brake) while simultaneously increasing anabolic signals like IGF-1 LR3 (pressing the accelerator) or optimizing androgen receptor sensitivity with a potent SARM like S-23 creates a multiplicative effect on muscle protein synthesis. This is advanced biohacking in action.
- Contrarian Take on “Natural” Limits: The very existence of myostatin as a universal growth limiter challenges the idea of a “natural” genetic ceiling. If everyone has a protein actively suppressing their potential, then using compounds to inhibit it is no different than using creatine to replenish ATP—it’s just another lever in the biochemical machinery of performance. The debate isn’t about natural vs. enhanced; it’s about how many levers you’re willing and able to pull.
Citations & References
- Lee, S. J., & McPherron, A. C. (2001). Regulation of myostatin activity and muscle growth. Proceedings of the National Academy of Sciences, 98(16), 9306-9311. (Seminal paper on myostatin function).
- Rodríguez, J., et al. (2019). (-)-Epicatechin enhances muscle endurance and ameliorates muscular dystrophy in mice. Journal of Nutritional Biochemistry, 65, 103-111. (Explores epicatechin’s effects on muscle metabolism and myostatin).
- Willoughby, D. S. (2004). Effects of heavy resistance training on myostatin mRNA and protein expression. Medicine and Science in Sports and Exercise, 36(4), 574-582. (Documents exercise-induced myostatin downregulation).
- Schuelke, M., et al. (2004). Myostatin mutation associated with gross muscle hypertrophy in a child. New England Journal of Medicine, 350(26), 2682-2688. (Landmark case study of a human with a myostatin mutation).
- Hulmi, J. J., et al. (2016). The effects of whey protein with or without carbohydrates on resistance training adaptations. Journal of the International Society of Sports Nutrition, 13, 48. (Includes data on resistance training and myostatin expression).
- Smith, R. C., & Lin, B. K. (2013). Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders. Current Opinion in Supportive and Palliative Care, 7(4), 352-360. (Reviews therapeutic potential of myostatin inhibition).